VALFIX Medical Ltd. is pleased to announce the issuance of US Patent No. 10,463,486 issued November 5th, 2019. This is the second US patent granted for VALFIX and was approved only 2 years and 9 months since its priority date.
VALFIX Medical Inc. announces today an investment from California based angel group, Life Science Angels (LSA). This investment is part of the company's third investment round and concludes a meticulous due diligence process led by Dr.